Imatinib (CAS 152459-95-5) is a tyrosine kinase inhibitor that appears as a white to off-white powder. It is an active pharmaceutical ingredient used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.
Imatinib
Category:Organic Intermediates
CAS No.:152459-95-5
Product Grade: Pharmaceutical Grade
Purity / Assay: 98%
Molecular Formula:C₂₉H₃₁N₇O
Molecular Weight:493.6
EINECS No.:604-855-6
Synonym(s):Imatinib free base; STI-571; Gleevec
Imatinib (CAS 152459-95-5) is a tyrosine kinase inhibitor that appears as a white to off-white powder. It is an active pharmaceutical ingredient used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.
1. BCR-ABL tyrosine kinase inhibitor for chronic myeloid leukemia.
2. Treatment of gastrointestinal stromal tumors.
3. Pharmaceutical reference standard and impurity profiling material.
4. Research reagent in tyrosine kinase signalling.
25kg/drum; 25kg/bag
CAS No.: 152459-95-5
Product Name: Imatinib
Purity / Assay:98%
Molecular Formula:C₂₉H₃₁N₇O
Molecular Weight:493.6
EINECS No.:604-855-6
Synonym(s):Imatinib free base; STI-571; Gleevec
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.